Biotech companies by days to cover
Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.
Immunovant leads the 24 biotech companies ranked by days to cover, at 15.3, ahead of Scholar Rock Holding (13.6) and CRISPR Therapeutics (13.1). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.
Key facts
- Companies ranked
- 24
- First
- Immunovant15.3
- Median
- 6.4
- Combined market value
- ZAR 14.44T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Days to cover ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ImmunovantIMVT · Health Care | 15.3 | ZAR 118.5B | ZAR 572.68 | 0.12% down | 43% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | 13.6 | ZAR 101.1B | ZAR 828.71 | 6.48% up | 14% up | ||
| 3 | CRISPR TherapeuticsCRSP · Health Care | 13.1 | ZAR 67.3B | ZAR 693.88 | 0.10% up | 21% down | ||
| 4 | Krystal BiotechKRYS · Health Care | 12.2 | ZAR 161.3B | ZAR 5,444.31 | 5.62% up | 46% up | ||
| 5 | ExelixisEXEL · Health Care | 11.7 | ZAR 287.7B | ZAR 1,179.02 | 0.31% down | 63% up | ||
| 6 | CG OncologyCGON · Health Care | 11.0 | ZAR 123.4B | ZAR 1,381.19 | 1.34% up | 85% up | ||
| 7 | ImmunityBioIBRX · Health Care | 10.8 | ZAR 123.1B | ZAR 115.67 | 7.03% up | 193% up | ||
| 8 | Kymera TherapeuticsKYMR · Health Care | 10.5 | ZAR 178.5B | ZAR 2,091.29 | 0.32% down | 87% up | ||
| 9 | Kodiak SciencesKOD · Health Care | 9.3 | ZAR 110.4B | ZAR 1,688.68 | 1.04% up | 396% up | ||
| 10 | Revolution MedicinesRVMD · Health Care | 7.8 | ZAR 596.8B | ZAR 2,759.27 | 1.76% down | 131% up | ||
| 11 | Halozyme TherapeuticsHALO · Health Care | 6.8 | ZAR 188.6B | ZAR 1,653.98 | 0.18% down | 37% up | ||
| 12 | VaxcytePCVX · Health Care | 6.7 | ZAR 159.9B | ZAR 1,010.34 | 1.48% down | 22% up | ||
| 13 | Adaptive BiotechnologiesADPT · Health Care | 6.1 | ZAR 79.5B | ZAR 491.36 | 0.11% down | 88% up | ||
| 14 | Neurocrine BiosciencesNBIX · Health Care | 5.4 | ZAR 284.6B | ZAR 2,811.76 | 1.84% down | 20% up | ||
| 15 | AmgenAMGN · Health Care | 5.0 | ZAR 4.15T | ZAR 7,663.71 | 3.07% down | 34% up | ||
| 16 | RepligenRGEN · Health Care | 4.9 | ZAR 190.6B | ZAR 2,981.13 | 6.47% up | 5% up | ||
| 17 | Twist BioscienceTWST · Health Care | 4.4 | ZAR 137B | ZAR 2,008.77 | 3.88% up | 340% up | ||
| 18 | BiogenBIIB · Health Care | 4.0 | ZAR 641.6B | ZAR 4,340.56 | 0.25% up | 49% up | ||
| 19 | argenxARGX · Health Care | 3.4 | ZAR 1.02T | ZAR 16,250.57 | 0.66% down | 4% up | ||
| 20 | Gilead SciencesGILD · Health Care | 3.2 | ZAR 3.62T | ZAR 2,917.42 | 0.75% down | 33% up | ||
| 21 | Bio-TechneTECH · Health Care | 2.7 | ZAR 197.3B | ZAR 1,256.02 | 0.17% up | 26% up | ||
| 22 | BioNTechBNTX · Health Care | 2.2 | ZAR 356.4B | ZAR 1,437.47 | 1.89% down | 16% down | ||
| 23 | ModernaMRNA · Health Care | 1.8 | ZAR 1.37T | ZAR 3,397.56 | 4.84% down | 755% up | ||
| 24 | QiagenQGEN · Health Care | 0.7 | ZAR 176.7B | ZAR 855.65 | 0.38% down | 12% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2649 ZAR).
Questions and answers
Which biotech companies rank first by days to cover?
Immunovant (15.3), Scholar Rock Holding (13.6) and CRISPR Therapeutics (13.1) are the top three of the 24 biotech companies ranked by days to cover as of the 30 Oct 2026 settlement date.
How many biotech companies are in this ranking?
24 are ranked by days to cover.
What are these biotech companies worth together?
The 24 biotech companies ranked by days to cover have a combined market value of ZAR 14.44T as of the 30 Oct 2026 settlement date.
What does ranking by days to cover measure?
Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Biotech companies by days to cover”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=days-to-cover
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.